Drainage before surgery for pancreatic cancer with jaundice
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a specific drainage step before surgery for patients with pancreatic head cancer who have severe jaundice. It aims to see if this approach improves outcomes compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic head cancer, confirmed by biopsy or a team of specialists.
- Your jaundice is caused by the tumor blocking the bile duct, and you are scheduled for a Whipple surgery.
- Your bilirubin level is 250 µmol/L or higher, and you have not had any bile duct drainage yet.
- You are between 18 and 75 years old.
- You are well enough to undergo surgery, with an ECOG performance status of 2 or lower.
- You can provide written consent, receive a preoperative endoscopic drainage procedure (ERCP), and be evaluated for the timing of radical surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of four drugs (liposomal irinotecan, 5-fluorouracil, oxaliplatin, and adebrelimab) given with radiation therapy before surgery for pancreatic cancer that can be surgically removed or is borderline removable. The goal is to shrink the tumor and improve the chances of successful surgery.
This study compares whether leaving a drainage tube (PTCD catheter) in place versus removing it during surgery for pancreatic cancer or similar tumors affects your recovery. The goal is to see which approach leads to better short-term outcomes after surgery.
This trial studies whether draining bile before surgery can help people with a bile-duct blockage caused by certain cancers. It aims to improve the situation before tumor removal by reducing the effects of a blocked, backed-up bile system.
This trial tests a combination of chemotherapy drugs (NALIRIFOX) given before and after surgery for people with pancreatic cancer that is at high risk of coming back but can still be surgically removed. The goal is to see if this treatment helps improve outcomes.
This trial tests whether a special geriatric care program before surgery can improve recovery and quality of life for adults 70 or older who need a major liver or pancreas operation for cancer.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.